Schedule 13D ownership disclosure
Immunovant Inc
Common Stock, par value $0.0001 per share · CUSIP: 45258J102
Event date: 2025-01-13
- Filing-level shares
- 96,660,341
- Percent of class
- 56.9%
- Roivant Sciences Ltd.Reported CIK 0001635088
Shares: 96,660,341 · Class: 56.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-001185
- Form type
- SCHEDULE 13D/A
- Filer
- Immunovant, Inc.
- CIK
- CIK 1764013
- Filed
- Jan 15, 2025
- Reporting period
- Jan 13, 2025
- Description
- Schedule 13D beneficial ownership